mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.03 |
mRNA |
TAE684 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
0.071 |
0.03 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.03 |
mRNA |
Cytarabine |
FIMM |
pan-cancer |
AAC |
0.31 |
0.04 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.04 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.04 |
mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.04 |